Aptevo Therapeutics APVO
-
-
-
已收盤:-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
---|---|---|---|---|---|---|
2025Q1 | 23.20 | -1 | -6 | -53.55 | 8 | |
2024Q4 | 86.20 | 5 | -137.59 | -6 | -41.07 | 16 |
2024Q3 | 133.05 | 4 | -114.85 | -5 | -33.93 | 15 |
2024Q2 | 226.44 | 4 | -111.36 | -6 | -36.15 | 15 |
2024Q1 | 3470.60 | 6 | -74.59 | -7 | -32.18 | 18 |
2023Q4 | 5893.44 | 12 | -43.82 | -6 | -22.72 | 25 |
2023Q3 | 10744.94 | 15 | -40.90 | -6 | -22.60 | 27 |
2023Q2 | 47538.22 | 16 | -40.23 | -8 | -24.88 | 29 |
2023Q1 | 66260.46 | 23 | 13.45 | 3 | 8.02 | 35 |
2022Q4 | 75540.18 | 18 | -27.52 | -5 | -14.09 | 34 |
2022Q3 | 98983.69 | 16 | -39.39 | -8 | -21.69 | 32 |
2022Q2 | 116566.32 | 23 | 28 | 66.70 | 39 | |
2022Q1 | 191129.68 | -6 | -8 | -15.12 | 45 | |
2021Q4 | 256250.53 | 1 | -147.44 | -6 | -10.40 | 57 |
2021Q3 | 502732.94 | 7 | -66.09 | -7 | -10.33 | 64 |
2021Q2 | 730330.29 | 14 | -65.06 | -8 | -11.31 | 71 |
2021Q1 | 993744.12 | 11 | -53.55 | -7 | -11.87 | 69 |
2020Q4 | 1193339.51 | 17 | -75.05 | -7 | -15.51 | 54 |
2020Q3 | 247459.22 | 2 | -125.16 | -7 | -24.28 | 37 |
2020Q2 | 271879.53 | 9 | -57.16 | -7 | -31.10 | 19 |